Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 23, Issue 9, 1996, Pages 1599-1604

  Ishiguro, Naoki ^a   Ito, Takayasu ^a   Obata, Ken Ichi ^b   Fujimoto, Noboru ^b   Iwata, Hisashi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJI CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

Matrix metalloproteinase; Rheumatoid arthritis; Synovial fluid; Tissue inhibitor of metalloproteinase

Indexed keywords

AUROTHIOMALATE; BUCILLAMINE; COLLAGENASE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SERUM; SKELETON RADIOGRAPHY; SYNOVIAL FLUID;

AGED; ARTHRITIS, RHEUMATOID; BLOOD; COLLAGENASES; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MOLECULAR WEIGHT; OSMOLAR CONCENTRATION; PROTEASE INHIBITORS; PROTEINS; SYNOVIAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0029739494     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mainardi CL: Biochemical mechanisms of articular destruction. Rheum Dis Clin North Am 1987;13:215-33.
2. Harris EJ: Rheumatoid arthritis: Pathophysiology and implications for therapy. New Engl J Med 1990;322:1277-89.
3. Vincenti MP, Clark IM, Brinckerhoff CE: Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum 1994;37:1115-26.
4. Ito A, Nagase H: Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase 1. Arch Biochem Biophys 1988;267:211-6.
5. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H: Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): Correlation with rheumatoid arthritis. Ann Rheum Dis 1989;48:645-53.
6. Mercer E, Cawston TE, DeSilva M, Hazleman BL: Purification of a metalloproteinase inhibitor from human rheumatoid synovial fluid. Biochem J 1985;231:505-10.
7. Hembry RM, Bagga MR, Murphy G, Henderson B, Reynolds JJ: Rabbit models of arthritis: Immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage. Am J Pathol 1993;143:628-42.
8. Martel PJ, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP: Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid. Lab Invest 1994;70:807-15.
9. Taylor DJ, Cheung NT, Dawes PT: Increased serum proMMP-3 in inflammatory arthritis: A potential indicator of synovial inflammatory monokine activity. Ann Rheum Dis 1994;53:768-72.
10. Sasaki S, Iwata H, Ishiguro N, Obata K, Miura T: Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis. Clin Rheumatol 1994;13:228-33.
11. Manicourt DH, Fujimoto N, Obata K, Thonar E J-M A: Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulafate in patients with osteoarthritis. Arthritis Rheum 1994;37:1774-83.
12. Yoshihara Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M: Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 1995;38:969-75.
13. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. J Immunol Methods 1990;127:103-8.
14. Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin Chim Acta 1995;220:31-45.
15. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 1993;221:91-103.
16. Obata K, Iwata K, Okada Y, et al: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta 1992;211:59-72.
17. Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 1994;231:79-88.
18. Larsen A, Dale K, Eek M: Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagnosis 1977;18:481-91.
19. Fuchs HA, Pincus T: Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum 1994;37:470-5.
20. Woessner JJ, Gunja SZ: Role of metalloproteinases in human osteoarthritis. J Rheumatol 1991;(suppl)27:99-101.
21. Ito A, Ito Y, Sasaguri Y: Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts. Arthritis Rheum 1992;35:1197-201.
22. Arend WP, Dayer J-M: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
23. Fava R, Olsen N, Keski-Oja J: Active and latent forms of transforming growth factor-b activity in synovial effusions. J Exp Med 1989;169:291-6.
24. McCachren SS, Greer PK, Niedel JE: Regulation of human synovial fibroblast collagenase messenger RNA by interleukin-1. Arthritis Rheum 1989;32:1539-45.
25. Koolwijk P, Miltenburg AM, van Erck MG, et al: Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J Rheumatol 1995;22:395-93.
26. Kleiner D Jr, Unsworth EJ, Krutzsch HC, Stetler-Stevenson WG: Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2. Biochemistry 1992;31:1665-72.
27. Millis AJ, Hoyle M, McCue HM, Martini H: Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts 1. Exp Cell Res 1992;201:313-9.
28. Apte SS, Hayashi K, Seldin MF, Mattei MG, Hayashi M, Olsen BR: Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, cartilage, and muscle, and is located on mouse chromosome 10. Dev Dyn 1994;200:177-97.
29. Xie DL, Hui F, Meyers R, Homandberg GA: Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: Stromelysin plays a major role in chondrolysis. Arch Biochem Biophys 1994;311:205-12.
30. Hanemaaijer R, Koolwijk P, Clercq L, Vree WJA, Hinsberg VWM: Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumor necrosis factor-alpha, interleukin-1 and phorbol ester. Biochem J 1993;296:803-9.